![](/img/cover-not-exists.png)
MA16.06 Phase I/II Study of AC0010, Mutant-Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation
Wu, Yi Long, Zhou, Qing, Liu, Xiaoqing, Zhang, Li, Zhou, Jianying, Wu, Lin, An, Tongtong, Cheng, Ying, Zheng, Xin, Hu, Bei, Jiang, Ji, Fang, Xin, Xu, Wanhong, Xu, XiaoVolume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.510
Date:
January, 2017
File:
PDF, 175 KB
english, 2017